Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$4.27B |
| 2 |
Apple
AAPL
|
+$2.66B |
| 3 |
Philip Morris
PM
|
+$1.71B |
| 4 |
Oracle
ORCL
|
+$1.63B |
| 5 |
NVIDIA
NVDA
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.92B |
| 2 |
UnitedHealth
UNH
|
+$2.3B |
| 3 |
Boeing
BA
|
+$2.28B |
| 4 |
Shopify
SHOP
|
+$1.22B |
| 5 |
Las Vegas Sands
LVS
|
+$1.09B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.32% |
| 2 | Healthcare | 13.6% |
| 3 | Consumer Discretionary | 12.18% |
| 4 | Financials | 10.03% |
| 5 | Industrials | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Grand Canyon Education
LOPE
$3.79B
| $71M | 0.01% |
426,644
-9,377
| -2% | -$1.7M |
|
327
Huazhu Hotels Group
HTHT
$12.5B
| $70.7M | 0.01% |
1,502,500
-4,058,057
| -73% | -$175M |
|
328
First Advantage
FA
$3.81B
| $70.7M | 0.01% |
4,864,471
-16,389
| -0.3% | -$231K |
|
329
Sempra
SRE
$56.5B
| $70.6M | 0.01% |
800,000
| – | – |
|
330
ESAB
ESAB
$5.29B
| $69.1M | 0.01% |
+618,502
| New | +$70.8M |
|
331
Edison International
EIX
$27.2B
| $68.9M | 0.01% |
1,148,661
+21,968
| +2% | +$1.26M |
|
332
Deere & Co
DE
$165B
| $66.4M | 0.01% |
142,707
+1,214
| +0.9% | +$570K |
|
|
WCC
333
WESCO International
WCC
$17.5B
| $66.4M | 0.01% |
271,476
+1,164
| +0.4% | +$285K |
|
334
Blue Owl Capital
OWL
$19.7B
| $64.2M | 0.01% |
4,299,836
+2,979,567
| +226% | +$46.6M |
|
335
Encompass Health
EHC
$12.2B
| $63.4M | 0.01% |
597,302
-5,219
| -0.9% | -$605K |
|
|
VIA
336
Via Transportation Inc
VIA
$2.15B
| $62.1M | 0.01% |
2,140,200
+1,297,114
| +154% | +$53.5M |
|
337
Berkshire Hathaway Class A
BRK.A
$1.09T
| $61.9M | 0.01% |
82
| – | – |
|
338
Denali Therapeutics
DNLI
$3.97B
| $61.6M | 0.01% |
3,729,244
-1,031,614
| -22% | -$17.4M |
|
339
Ezcorp Inc
EZPW
$1.76B
| $61.5M | 0.01% |
3,167,748
+1,019,622
| +47% | +$19.2M |
|
340
Tetra Tech
TTEK
$9.33B
| $59.6M | 0.01% |
1,775,766
-11,337
| -0.6% | -$383K |
|
341
Establishment Labs
ESTA
$2.25B
| $58.9M | 0.01% |
807,826
-6,665
| -0.8% | -$402K |
|
342
e.l.f. Beauty
ELF
$5.43B
| $58.3M | 0.01% |
766,072
+219,840
| +40% | +$21.6M |
|
343
Saia
SAIA
$10.1B
| $57.5M | 0.01% |
+176,035
| New | +$53.2M |
|
344
Shell
SHEL
$248B
| $56.9M | 0.01% |
773,911
+301
| +0% | +$22.2K |
|
345
Welltower
WELL
$169B
| $56.9M | 0.01% |
306,310
| – | – |
|
346
Moog Inc Class A
MOG.A
$13.5B
| $51.2M | 0.01% |
210,179
+5,830
| +3% | +$1.28M |
|
347
StepStone Group
STEP
$4.28B
| $51M | 0.01% |
794,883
| – | – |
|
348
International Flavors & Fragrances
IFF
$21.4B
| $50.8M | 0.01% |
753,785
| – | – |
|
349
St. Joe Company
JOE
$3.89B
| $48.9M | 0.01% |
823,697
-106,521
| -11% | -$5.97M |
|
350
Cameco
CCJ
$42.6B
| $48.5M | 0.01% |
529,699
+90,948
| +21% | +$8.19M |
|
Similar funds
Capital Research Global Investors's Q4 2025 Portfolio in Review
As of Q4 2025, Capital Research Global Investors held 465 positions worth $542B, up 1.6% from $533B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Capital Research Global Investors's Q4 2025 filing shows 31 new, 212 increased, 169 reduced and 31 closed positions. Its largest new stake was Medline Inc: 14,784,203 shares worth $621M. The largest sale was Meta Platforms (Facebook), an estimated $3.92B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q4 2025 buy was Medline Inc: 14,784,203 shares worth $621M.
- Capital Research Global Investors added most to Applied Materials in Q4 2025, an estimated $4.27B increase.
- Capital Research Global Investors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $3.92B.
- Capital Research Global Investors fully exited nVent Electric in Q4 2025, selling an estimated $379M.
- Capital Research Global Investors's ten largest holdings make up 39% of its $542B portfolio in Q4 2025.
- Capital Research Global Investors opened 31 new positions and closed 31 in Q4 2025.
- Capital Research Global Investors's portfolio value rose 1.6% quarter-over-quarter to $542B.
Based on Capital Research Global Investors's 13F filing for Q4 2025, filed 11 Feb 2026.